We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Charles P. Vega, MD
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for ICH?
Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World Data
Jan Beyer-Westendorf, MD, PhD
Craig I. Coleman, PharmD, FASHP
Deborah Siegal, MD, MSc, FRCPC
What’s the Best Available Evidence for Reversal of Life-Threatening Bleeds?
Setting the Stage: Case Considerations for Bleeding Management in Anticoagulated Patients
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for GI Bleeds?
Clinical and Practical Viability of RWE – What Now?
Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?
What Future Studies Are Out There on the Meaningfulness of Reversal in ICH?
Anticoagulant-Associated Major Bleeding Is a Significant Problem: How Do I Address?
Anticoagulation Reversal: Real-World Data Matters, Too
Mark Crowther, MD, MSc, FRCPC, FRSC
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education